Secondary Headaches, ICHD-3 Appendix Entities, and Regional Perspectives: Focus on India

Understanding Secondary Headache Diagnostic Criteria

Secondary headaches are symptomatic manifestations of underlying vascular, structural, infectious, metabolic, or toxic disorders . Under ICHD-3, diagnostic criteria no longer require complete remission or substantial improvement of the underlying causal disorder before a secondary headache diagnosis can be formally assigned .

Standardized ICHD-3 Secondary Headache Criteria

A secondary headache diagnosis requires:

  • Criterion A: A headache fulfilling relevant clinical features.

  • Criterion B: Diagnostic confirmation of a causal underlying disorder.

  • Criterion C: Evidence of causation demonstrated by at least two of the following:

    1. Temporal development in relation to the onset of the causative disorder.

    2. Parallel worsening or improvement matching the course of the causative disorder.

    3. Characteristics typical for the causative entity.

    4. Other direct causal evidence.

  • Criterion D: Not better accounted for by another ICHD-3 diagnosis.

Key Updates in Specific Secondary Subtypes

  • Post-Traumatic Headache (PTHA): ICHD-3 expanded the onset window for PTHA to within 7 days post-trauma, or within 7 days after regaining consciousness, or within 7 days following the discontinuation of medications that impair sensory perception post-injury.

  • Medication-Overuse Headache (MOH): Defined as headache occurring on $\ge 15$ days per month in a patient with a pre-existing headache disorder. Diagnostic thresholds require usage of ergotamines, triptans, opioids, or combination analgesics on $\ge 10$ days per month, or simple analgesics on $\ge 15$ days per month for $>3$ months. Unlike ICHD-2, ICHD-3 does not require resolution after medication withdrawal to confirm the diagnosis.

What’s New in the ICHD-3 Appendix?

The ICHD-3 Appendix serves as a research repository for novel or emerging headache entities pending definitive validation:

Selected Emerging Appendix Entities

  • A1.6.5 Vestibular Migraine: Characterized by episodic vestibular symptoms (vertigo) directly attributed to a migrainous mechanism.

  • A1.6.1.3 Infantile Colic: Recognized as a periodic syndrome and childhood precursor to migraine.

  • A4.11 Epicrania Fugax: Paroxysmal, brief head pain moving in a zig-zag trajectory across the scalp.

  • A10.1.2 Airplane Headache: Headache triggered specifically by altitude and cabin pressure changes during atmospheric flight.

  • A10.10 "Coat Hanger" Pain: Nuchal and shoulder girdle pain attributed to orthostatic hypotension and cerebral hypoperfusion.

  • Psychiatric Attributions (A12.3–A12.10): Headaches directly attributed to Depressive Disorders, Panic Disorder, Generalized Anxiety Disorder, PTSD, and Acute Stress Disorder.

Critical Analysis and Limitations of ICHD-3

Despite its clinical utility, neuro-specialists have identified operational limitations in the ICHD-3 beta criteria:

  1. Lack of Severity Coding: ICHD-3 does not provide numeric codes for headache severity or frequency, requiring free-text annotation.

  2. Aura Duration & Ischemia Gaps: Typical auras lasting between 1 hour and 1 week are categorized as "Probable Migraine with Aura," creating diagnostic ambiguity. Furthermore, auras causing permanent deficits without visible MRI ischemic changes fail to meet criteria for Migrainous Infarction.

  3. Migraine with Brainstem Aura Concerns: Requiring at least two brainstem symptoms excludes patients presenting with vertigo as an isolated aura symptom.

  4. Arbitrary Chronic Thresholds: The strict 15-day/month boundary separating episodic from chronic migraine is considered arbitrary in continuous clinical spectrums.

Regional Insights: Unique Perspectives on Headache in India

Headache disorders present distinct epidemiological, clinical, and socio-economic challenges in India:

Epidemiological Distribution in Indian Headache Clinics Analysis of clinical cohorts (e.g., Ravishankar K.) reveals a distinct distribution pattern in India:

  • Migraine with Aura: 47%

  • Migraine without Aura: 4%

  • Other Categories: 43%

  • Unclassifiable Presentations: 6%

Epidemiological Breakdown (Indian Clinic Study):
[Migraine with Aura: 47%] [Migraine without Aura: 4%] [Other Categories: 43%] [Unclassifiable: 6%]

Socio-Cultural and Environmental Triggers In addition to standard biological triggers, clinical practice in India requires identifying specific environmental and socio-cultural provoking factors:

  • Environmental stressors: High vehicular/industrial pollution, extreme hot climates, and loud festival crowds/noise.

  • Cultural & Lifestyle factors: Dietary triggers (spicy, oily, fried foods), religious fasting practices, and exposure to burning incense sticks (agarbatti) or mosquito coils.

  • Topical preparations: Application of henna / hair dyes.

  • Psychosocial dynamics: Academic stress within the education system, joint family stress, and stressful travel conditions.

  • Health System Challenges: Primary care prioritization often favors infectious diseases (TB, HIV, Malaria) over chronic non-communicable headache disorders, contributing to under-diagnosis.

Key Takeaways

  1. Screen for Medication Overuse: In patients presenting with daily headaches, calculate monthly analgesic intake to rule out Medication-Overuse Headache.

  2. Consider Environmental Triggers: Patient management in diverse geographical settings requires taking detailed lifestyle histories that account for local environmental and cultural triggers.

  3. Monitor Appendix Revisions: Keep updated with research entities in the ICHD-3 Appendix (e.g., Vestibular Migraine) as they transition into mainstream clinical practice.